Waldencast plc (WALD)

NASDAQ: WALD · Real-Time Price · USD
0.9902
-0.0298 (-2.92%)
At close: Mar 27, 2026, 4:00 PM EDT
0.9801
-0.0101 (-1.02%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Market Cap115.87M -67.1%
Revenue (ttm)272.07M -0.7%
Net Income-229.75M
EPS-2.01
Shares Out 118.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume181,607
Open1.0300
Previous Close1.0200
Day's Range0.9800 - 1.0500
52-Week Range0.9800 - 3.2200
Beta-0.45
AnalystsStrong Buy
Price Target3.70 (+273.66%)
Earnings DateMar 13, 2026

About WALD

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as w... [Read more]

Sector Financials
IPO Date Mar 16, 2021
Employees 367
Stock Exchange NASDAQ
Ticker Symbol WALD
Full Company Profile

Analyst Summary

According to 5 analysts, the average rating for WALD stock is "Strong Buy." The 12-month stock price target is $3.7, which is an increase of 273.66% from the latest price.

Price Target
$3.7
(273.66% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness

The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nine signs of skin aging for healthier, more resilient-looking skin The clinically proven formula pairs...

3 days ago - GlobeNewsWire

Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™

ProMD's multi-location physician led network will participate in Obagi's ALOHA Program as part of a structured evaluation of MagIQ and integrated skincare protocols to providers across multiple states...

8 days ago - GlobeNewsWire

Waldencast Reports Q4 2025 and FY 2025 Financial Results

FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical see...

14 days ago - GlobeNewsWire

Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date

LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform announced that its Fourth Quarter and Fiscal Year 2025 earni...

16 days ago - GlobeNewsWire

Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its extensive national network of practices Sc...

4 weeks ago - GlobeNewsWire

Obagi Medical and It's a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

It's a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing ne...

4 weeks ago - GlobeNewsWire

Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic prac...

5 weeks ago - GlobeNewsWire

Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices DermFx selected as a ...

7 weeks ago - GlobeNewsWire

Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Moxie selected as a leading aesthetic practice software and support partner for its commitment to innovation, compliance, and empowering aesthetic entrepreneurs Moxie selected as a leading aesthetic p...

7 weeks ago - GlobeNewsWire

Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect

The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protection for visibly smoother lips The dermatologist-tested duo pairs gentle chemical resurfacing with dai...

7 weeks ago - GlobeNewsWire

Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care VIO Med Spa selected as a key med spa franchise pa...

2 months ago - GlobeNewsWire

Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Next Health selected as a leading wellness and longevity partner given its innovative approach to personalized aesthetics and health optimization Next Health selected as a leading wellness and longevi...

2 months ago - GlobeNewsWire

UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers Alpha selected as the first Medspa platform partner given their commi...

2 months ago - GlobeNewsWire

Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers Alpha selected as the first Medspa platform partner given their commi...

2 months ago - GlobeNewsWire

CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices Platinum selected as the first dermatology plat...

2 months ago - GlobeNewsWire

Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler

Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare

2 months ago - GlobeNewsWire

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation

4 months ago - GlobeNewsWire

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold its righ...

4 months ago - GlobeNewsWire

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

First Half Fiscal 2025 Results and Q3 2025 Financial Results Expected to be Reported on November 24, 2025 First Half Fiscal 2025 Results and Q3 2025 Financial Results Expected to be Reported on Novemb...

4 months ago - GlobeNewsWire

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

A Next-Generation, Redensifying Scalp Serum Clinically Proven to Promote Fuller, Denser-Looking Hair* A Next-Generation, Redensifying Scalp Serum Clinically Proven to Promote Fuller, Denser-Looking Ha...

6 months ago - GlobeNewsWire

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market U.S. Launch...

7 months ago - GlobeNewsWire

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S.

7 months ago - GlobeNewsWire

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Waldencast plc WALD will release earnings results for the second quarter after the closing bell on Monday, Aug. 18.

7 months ago - Benzinga

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics...

8 months ago - GlobeNewsWire

Waldencast: Learning To Grow Hurts Sometimes

Waldencast is a fast-growing beauty company with strong brands (Milk Makeup, Obagi), but faces margin pressure and negative earnings due to high SG&A and debt. Recent revenue growth remains solid, but...

10 months ago - Seeking Alpha